Treatment Strategies and Key Takeaways for Metastatic Non-Small Cell Lung Cancer

A detailed discussion on the use of immunotherapy drugs like nevoleumab, atesalizumab, and pembrolizumab for treating metastatic non-small cell lung cancer, emphasizing the significance of chemotherapy backbones, actionable mutations, and targeted agents based on PDL1 status.